|
|
|||||||
Journal Article |
Divisione Ematologica, Ospedale di Pesaro, Italy.
The presence of anti-HCV antibodies has been examined in a group of 256 consecutive thalassemic patients who received blood transfusions in several countries around the world. Overall 60% were found to be anti-HCV positive. A higher incidence of anti-HCV antibodies was noted in Italian patients with respect to patients living in Eastern countries, and in southern Italy with respect to northern Italy. Because these patients received a large portion of their transfusions before the anti-HCV test became available, these data indicate a higher anti-HCV seroprevalence among Italian blood donors and confirm published data indicating a higher seroprevalence in southern Italy. The anti-seropositivity correlated highly with serum transaminase elevation and with histological diagnoses of chronic active hepatitis.
This article has been cited by other articles:
![]() |
E. Angelucci and F. Pilo Treatment of hepatitis C in patients with thalassemia Haematologica, August 1, 2008; 93(8): 1121 - 1123. [Full Text] [PDF] |
||||
![]() |
P. Muretto, E. Angelucci, and G. Lucarelli Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation Ann Intern Med, May 7, 2002; 136(9): 667 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Di Marco, O. L. Iacono, P. Almasio, C. Ciaccio, M. Capra, M. Rizzo, R. Malizia, A. Maggio, C. Fabiano, F. Barbaria, et al. Long-Term Efficacy of alpha -Interferon in beta -Thalassemics With Chronic Hepatitis C Blood, September 15, 1997; 90(6): 2207 - 2212. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |